Bis-Trimethylammonium Compounds

DBCAT001922Pharmacologic class

Compounds containing polymethylene bis-trimethylammonium cations. Members of this group frequently act as ganglionic blockers and neuromuscular depolarizing agents. A DrugBank category of 4 drugs. 2 of them are approved.

Also known as: Bis Trimethyl Ammonium Compounds · Bis Trimethylammonium Compounds · Bis-Trimethyl-Ammonium Compounds · Methonium Compounds
Drugs: Decamethonium
Decamethoxine
Hexafluronium
Hexamethonium

What you can answer from here — as of August 24, 2016

4DrugsEach linked to its full drug card

Listed above

8Drug targetsEvery drug–target pair in the class, with bond type

Which targets do Bis-Trimethylammonium Compounds share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account